TEST BANK $ol
Rau's Respiratory Care Pharmacology 11th
$ol $ol $ol $ol
Edition by Douglas S. Gardenhire.
$ol $ol $ol $ol $ol
FULL TEST BANK!!!
$ol $ol
,Description
Test $olBank $olfor $olRau’s $olRespiratory $olCare $olPharmacology $ol11th $olEdition $olGardenhire
Test $olBank $olfor $olRau’s $olRespiratory $olCare $olPharmacology, $ol11th $olEdition, $olGardenhire, $olISBN-
$ol10:0323871550, $olISBN-13: $ol978-0323871556
Table $olof $olContents
Unit $olI: $olBasic $olConcepts $oland $olPrinciples $olin $olPharmacology
1. $olIntroduction $olto $olRespiratory $olCare $olPharmacology
2. $olPrinciples $olof $olDrug $olAction
3. $olAdministration $olof $olAerosolized $olAgents
4. $olCalculating $olDrug $olDoses
5. $olThe $olCentral $oland $olPeripheral $olNervous $olSystems
Unit $olII: $olDrugs $olUsed $olto $olTreat $olthe $olRespiratory $olSystem
6. $olAdrenergic $ol(Sympathomimetic) $olBronchodilators
7. $olAnticholinergic $ol(Parasympatholytic) $olBronchodilators
8. $olXanthines
9. $olMucus-Controlling $olDrug $olTherapy
10. $olSurfactant $olAgents
11. $olCorticosteriods $olin $olRespiratory $olCare
12. $olNonsteroidal $olAntiasthma $olAgents
13. $olAerosolized $olAntiinfective $olAgents
14. $olAntimicrobial $olAgents
15. $olCold $oland $olCough $olAgents
16. $olSelected $olAgents $olof $olPulmonary $olValue
17. $olNeonatal $oland $olPediatric $olAerosolized $olDrug $olTherapy
Unit $olIII: $olCritical $olCare, $olCardiovascular, $oland $olPolysomnography $olAgents
18. $olSkeletal $olMuscle $olRelaxants $ol(Neuromuscular $olBlocking $olAgents)
19. $olDiuretic $olAgents
20. $olDrugs $olAffecting $olthe $olCentral $olNervous $olSystem
21. $olVasopressors, $olInotropes, $oland $olAntiarrythmic $olAgents
22. $olDrugs $olAffecting $olCirculation: $olAntihypertensives, $olAntianginals, $olAntithrombotics
23. $olSleep $oland $olSleep $olPharmacology
,Chapter 01: Introduction to Respiratory Care Pharmacology
Gardenhire: Rau’s Respiratory Care Pharmacology, 11th Edition
MULTIPLE CHOICE
1. What is the name of the receptor sites that are located in the peripheral vasculature, the heart, bronchial
muscle, and bronchial blood vessels?
a. Beta 2 receptors c. Alpha receptors
b. Gamma receptors d. Beta 1 receptors
ANS: C
Alpha receptors are located in the peripheral vasculature, the heart, bronchial muscle, and bronchial
blood vessels.
PTS: 1
2. Which receptor site results in tachycardia, an increased potential for arrhythmias, and an increased
cardiac output?
a. Beta 1 receptor c. Alpha receptor
b. Beta 2 receptor d. Delta receptor
ANS: A
Stimulation of the beta-1 receptors results in tachycardia, an increased potential for arrhythmias, and
an increased cardiac output. In administering drugs to the pulmonary system, stimulation of the beta-1
sites is not desired. However, most respiratory pharmacologic agents have some beta-1 stimulatory
effect.
PTS: 1
3. Stimulation of the beta 2 receptors causes
a. peripheral vasoconstriction and mild bronchoconstriction in the lungs.
b. tachycardia, an increased potential for arrhythmias, and an increased cardiac output.
c. bronchodilation.
d. peripheral vasodilation, bradycardia, and decreased cardiac output.
ANS: C
Stimulation of the beta-2 receptors in the lungs causes bronchodilation.
PTS: 1
4. Acetylcholine stimulates
a. the Vagus nerve.
b. the adrenergic receptors.
c. the sympathetic nervous system.
d. the cholinergic receptors.
ANS: D
Acetylcholine stimulates the cholinergic receptors.
PTS: 1
5. What immunoglobulin antibody sensitizes the mast cell?
a. Leukotrienes c. Histamine
, b. IgE d. $ o l Prostaglandins
ANS: $ o l B
The $olIgE $ol(reagin) $olantibodies $olsensitize $olthe $olmast $olcell. $olRepeated $olexposure $olto $olthe $olantigen $olcauses
$olthe $oldegranulation $olof $olthe $olmast $olcell.
PTS: $ o l 1
6. Which $olof $olthe $olfollowing $olis $olcaused $olby $olhistamine $olrelease $olfrom $olthe $olmast $olcells?
I. Bronchodilation
II. Increased $olbronchial $olgland $olsecretion
III. Increased $olamount $olof $olmucus $olpresent $olin $olthe $olairways
a. I $oland $olII $olonly c. III $olonly
b. II $oland $olIII $olonly d. $ o l $ o l I, $olII, $olIII
ANS: $ o l B
Histamine $olis $olalso $ola $olpotent $olbronchoconstrictor. $olIn $oladdition $olto $olits $olbronchoconstrictive $olactivity, $olhistamine
II) $olincreases $olbronchial $olgland $olsecretion, $olcausing $olIII) $olan $olincrease $olin $olthe $olamount $olof
$olmucus $olpresent $olin $olthe $olairways. $olHistamine $olmay $olalso $olhave $olan $oleffect $olon $olvascular
$olpermeability $olsimilar $olto $olthe $oleffect $olof- $olSRS-A.
PTS: $ o l 1
7. A$olsympathomimetic $oldrug $olwould $olcause $ol
a. bronchodilation. c. Histamine $olrelease.
b. bronchoconstriction. d. $olVagus $olnerve $olstimulation.
ANS: $ o l A
A $olsympathomimetic $oldrug $olwould $olcause $olbronchodilation. $olSympathomimetic $olagents $olare $olthe
$oldrugs $olmost $olcommonly $olused $olto $olreverse $olbronchospasm.
PTS: $ o l 1
8. Stimulation $olof $olthe $olsympathetic $olnervous $olsystem $olcauses $ol
a. vascular $olpermeability. c. bronchodilation.
b. decreased $olblood $olpressure. d. $ o l bronchoconstriction.
ANS: $ o l C
Sympathetic $olnervous $olsystem $olstimulation $olcauses $olbronchodilation.
PTS: $ o l 1
9. Which $olof $olthe $olfollowing $olwould $olNOT $olcause $ola $olbronchospasm $olor $olbronchoconstriction?
a. Leukotrienes c. Histamine
b. Beta $ol1 $olreceptors d. $ o l Prostaglandins
ANS: $ o l B
Beta-1 $olreceptors $olwould $olnot $olcause $ola $olbronchospasm $olor $olbronchoconstriction. $olLeukotrienes
$olare $olone $olof $olmany $olchemical $olmediators $olreleased $olby $olthe $olmast $olcells. $olLeukotrienes $olcause $ola
$oldirect, $olstrong $olbronchoconstriction. $olHistamine $olis $olalso $ola $olpotent $olbronchoconstrictor.
$olProstaglandins $olcause $ola $olstrong $olbronchospasm, $olespecially $olin $olasthmatic $olpatients.
PTS: $ o l 1
Rau's Respiratory Care Pharmacology 11th
$ol $ol $ol $ol
Edition by Douglas S. Gardenhire.
$ol $ol $ol $ol $ol
FULL TEST BANK!!!
$ol $ol
,Description
Test $olBank $olfor $olRau’s $olRespiratory $olCare $olPharmacology $ol11th $olEdition $olGardenhire
Test $olBank $olfor $olRau’s $olRespiratory $olCare $olPharmacology, $ol11th $olEdition, $olGardenhire, $olISBN-
$ol10:0323871550, $olISBN-13: $ol978-0323871556
Table $olof $olContents
Unit $olI: $olBasic $olConcepts $oland $olPrinciples $olin $olPharmacology
1. $olIntroduction $olto $olRespiratory $olCare $olPharmacology
2. $olPrinciples $olof $olDrug $olAction
3. $olAdministration $olof $olAerosolized $olAgents
4. $olCalculating $olDrug $olDoses
5. $olThe $olCentral $oland $olPeripheral $olNervous $olSystems
Unit $olII: $olDrugs $olUsed $olto $olTreat $olthe $olRespiratory $olSystem
6. $olAdrenergic $ol(Sympathomimetic) $olBronchodilators
7. $olAnticholinergic $ol(Parasympatholytic) $olBronchodilators
8. $olXanthines
9. $olMucus-Controlling $olDrug $olTherapy
10. $olSurfactant $olAgents
11. $olCorticosteriods $olin $olRespiratory $olCare
12. $olNonsteroidal $olAntiasthma $olAgents
13. $olAerosolized $olAntiinfective $olAgents
14. $olAntimicrobial $olAgents
15. $olCold $oland $olCough $olAgents
16. $olSelected $olAgents $olof $olPulmonary $olValue
17. $olNeonatal $oland $olPediatric $olAerosolized $olDrug $olTherapy
Unit $olIII: $olCritical $olCare, $olCardiovascular, $oland $olPolysomnography $olAgents
18. $olSkeletal $olMuscle $olRelaxants $ol(Neuromuscular $olBlocking $olAgents)
19. $olDiuretic $olAgents
20. $olDrugs $olAffecting $olthe $olCentral $olNervous $olSystem
21. $olVasopressors, $olInotropes, $oland $olAntiarrythmic $olAgents
22. $olDrugs $olAffecting $olCirculation: $olAntihypertensives, $olAntianginals, $olAntithrombotics
23. $olSleep $oland $olSleep $olPharmacology
,Chapter 01: Introduction to Respiratory Care Pharmacology
Gardenhire: Rau’s Respiratory Care Pharmacology, 11th Edition
MULTIPLE CHOICE
1. What is the name of the receptor sites that are located in the peripheral vasculature, the heart, bronchial
muscle, and bronchial blood vessels?
a. Beta 2 receptors c. Alpha receptors
b. Gamma receptors d. Beta 1 receptors
ANS: C
Alpha receptors are located in the peripheral vasculature, the heart, bronchial muscle, and bronchial
blood vessels.
PTS: 1
2. Which receptor site results in tachycardia, an increased potential for arrhythmias, and an increased
cardiac output?
a. Beta 1 receptor c. Alpha receptor
b. Beta 2 receptor d. Delta receptor
ANS: A
Stimulation of the beta-1 receptors results in tachycardia, an increased potential for arrhythmias, and
an increased cardiac output. In administering drugs to the pulmonary system, stimulation of the beta-1
sites is not desired. However, most respiratory pharmacologic agents have some beta-1 stimulatory
effect.
PTS: 1
3. Stimulation of the beta 2 receptors causes
a. peripheral vasoconstriction and mild bronchoconstriction in the lungs.
b. tachycardia, an increased potential for arrhythmias, and an increased cardiac output.
c. bronchodilation.
d. peripheral vasodilation, bradycardia, and decreased cardiac output.
ANS: C
Stimulation of the beta-2 receptors in the lungs causes bronchodilation.
PTS: 1
4. Acetylcholine stimulates
a. the Vagus nerve.
b. the adrenergic receptors.
c. the sympathetic nervous system.
d. the cholinergic receptors.
ANS: D
Acetylcholine stimulates the cholinergic receptors.
PTS: 1
5. What immunoglobulin antibody sensitizes the mast cell?
a. Leukotrienes c. Histamine
, b. IgE d. $ o l Prostaglandins
ANS: $ o l B
The $olIgE $ol(reagin) $olantibodies $olsensitize $olthe $olmast $olcell. $olRepeated $olexposure $olto $olthe $olantigen $olcauses
$olthe $oldegranulation $olof $olthe $olmast $olcell.
PTS: $ o l 1
6. Which $olof $olthe $olfollowing $olis $olcaused $olby $olhistamine $olrelease $olfrom $olthe $olmast $olcells?
I. Bronchodilation
II. Increased $olbronchial $olgland $olsecretion
III. Increased $olamount $olof $olmucus $olpresent $olin $olthe $olairways
a. I $oland $olII $olonly c. III $olonly
b. II $oland $olIII $olonly d. $ o l $ o l I, $olII, $olIII
ANS: $ o l B
Histamine $olis $olalso $ola $olpotent $olbronchoconstrictor. $olIn $oladdition $olto $olits $olbronchoconstrictive $olactivity, $olhistamine
II) $olincreases $olbronchial $olgland $olsecretion, $olcausing $olIII) $olan $olincrease $olin $olthe $olamount $olof
$olmucus $olpresent $olin $olthe $olairways. $olHistamine $olmay $olalso $olhave $olan $oleffect $olon $olvascular
$olpermeability $olsimilar $olto $olthe $oleffect $olof- $olSRS-A.
PTS: $ o l 1
7. A$olsympathomimetic $oldrug $olwould $olcause $ol
a. bronchodilation. c. Histamine $olrelease.
b. bronchoconstriction. d. $olVagus $olnerve $olstimulation.
ANS: $ o l A
A $olsympathomimetic $oldrug $olwould $olcause $olbronchodilation. $olSympathomimetic $olagents $olare $olthe
$oldrugs $olmost $olcommonly $olused $olto $olreverse $olbronchospasm.
PTS: $ o l 1
8. Stimulation $olof $olthe $olsympathetic $olnervous $olsystem $olcauses $ol
a. vascular $olpermeability. c. bronchodilation.
b. decreased $olblood $olpressure. d. $ o l bronchoconstriction.
ANS: $ o l C
Sympathetic $olnervous $olsystem $olstimulation $olcauses $olbronchodilation.
PTS: $ o l 1
9. Which $olof $olthe $olfollowing $olwould $olNOT $olcause $ola $olbronchospasm $olor $olbronchoconstriction?
a. Leukotrienes c. Histamine
b. Beta $ol1 $olreceptors d. $ o l Prostaglandins
ANS: $ o l B
Beta-1 $olreceptors $olwould $olnot $olcause $ola $olbronchospasm $olor $olbronchoconstriction. $olLeukotrienes
$olare $olone $olof $olmany $olchemical $olmediators $olreleased $olby $olthe $olmast $olcells. $olLeukotrienes $olcause $ola
$oldirect, $olstrong $olbronchoconstriction. $olHistamine $olis $olalso $ola $olpotent $olbronchoconstrictor.
$olProstaglandins $olcause $ola $olstrong $olbronchospasm, $olespecially $olin $olasthmatic $olpatients.
PTS: $ o l 1
